Long-term Prostate Cancer Treatment Outcomes

Tuesday, October 10, 2017
From November 1994 through January 2002, researchers from the Minneapolis Veterans Affairs Health Care System and other healthcare facilities in the United States randomly assigned 731 men with localized prostate cancer to undergo radical prostatectomy or observation. They extended follow-up through August 2014 for the primary outcome of the study, all-cause mortality, and the main secondary outcome, prostate-cancer mortality.

During 19.5 years of follow-up (median, 12.7 years), death occurred in 223 of 364 men (61.3%) who underwent radical prostatectomy and in 245 of 367 (66.8%) who were observed. Death attributed to prostate cancer or its treatment occurred in 27 men (7.4%) assigned to surgery and in 42 men (11.4%) assigned to observation. Treatment for disease progression was less frequent with surgery than with observation. Urinary incontinence and erectile and sexual dysfunction were each greater with surgery than with observation through 10 years of follow-up.

The researchers concluded that after nearly 20 years of follow-up of men with localized prostate cancer, radical prostatectomy was not associated with significantly lower all-cause or prostate-cancer mortality than observation. The study findings are available here.

Talk about this article with nurses and others in the oncology community in the General Discussions Oncology Nursing News discussion group.
Lisa Schulmeister, MN, RN, ACNS-BC, FAAN
Blog Info
Lisa Schulmeister, MN, RN, ACNS-BC, FAAN is an oncology nursing consultant and editor-in-chief of Oncology Nursing News.
Author Bio
Lisa Schulmeister, MN, RN, ACNS-BC, FAAN, is the Editor-in-Chief for OncLive Nursing. She is an oncology nursing consultant and adjunct assistant professor of nursing at Louisiana State Health Sciences Center in New Orleans, LA. She provides continuing nursing education to nurses across the Unites States, is active in several professional nursing organizations, and is intrigued by the many ways nurses use technology to communicate.
External Resources

MJH Associates
American Journal of Managed Care
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
OncNurse Resources

Continuing Education
Web Exclusives

About Us
Advisory Board
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2018
Intellisphere, LLC. All Rights Reserved.